Ellen Cahir-McFarland

Company: Abata Therapeutics

Job title: Chief Scientific Officer

Seminars:

Transforming Treg Biology Into Therapeutics for MS & T1D 1:00 pm

• Discussing a platform that enables quick TCR discovery and plug and play manufacturing • Highlighting autologous Treg therapies for tissue specific auto immune diseases such as progressive MS and T1DRead more

day: Day Two Track A, PM